Literature DB >> 19364496

p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation.

A Furuhata1, A Kimura, K Shide, K Shimoda, M Murakami, H Ito, S Gao, K Yoshida, Y Tagawa, K Hagiwara, A Takagi, T Kojima, M Suzuki, A Abe, T Naoe, T Murate.   

Abstract

Janus kinase 2 (JAK2) V617F mutation has been regarded as the major cause of myeloproliferative disorders (MPD). However, the mechanisms of abnormal cell growth by JAK2V617F have not been elucidated. In this study, cell cycle regulatory protein expression was analyzed using JAK2V617F-Ba/F3 and mock-Ba/F3. JAK2V617F-Ba/F3, but not mock-Ba/F3, showed IL-3 independent cell growth and constitutive STATs activation. Deregulation of p27(Kip1), the cell cycle regulator at the G1 to S transition, was observed in JAK2V617F-Ba/F3 but not in mock-control. p27(Kip1) deregulation was not due to p27(Kip1) mRNA level but due to high Skp2 expression, a subunit of ubiquitin E3 ligase, through the STAT binding in the Skp2 promoter. Like JAK2V617F overexpression, constitutively active STAT5 or STAT3 induced aberrant p27(Kip1) expression of Ba/F3 cells. Similar findings were observed in BCR/ABL-transfected Ba/F3. Our results elucidate the regulatory mechanism by which JAK2V617F modulates Skp2 gene expression through the STAT transcription factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364496     DOI: 10.1016/j.bbrc.2009.04.015

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.

Authors:  Clara Curiel-Lewandrowski; Hisato Yamasaki; Chuan Ping Si; Xiaoyi Jin; Yujun Zhang; Jillian Richmond; Marina Tuzova; Kevin Wilson; Beth Sullivan; David Jones; Nataliya Ryzhenko; Frederick Little; Thomas S Kupper; David M Center; William W Cruikshank
Journal:  J Clin Invest       Date:  2011-11-14       Impact factor: 14.808

2.  14-3-3β Depletion Drives a Senescence Program in Glioblastoma Cells Through the ERK/SKP2/p27 Pathway.

Authors:  Sung Bin Seo; Je-Jung Lee; Hye Hyeon Yun; Chang-Nim Im; Yong-Sam Kim; Jeong-Heon Ko; Jeong-Hwa Lee
Journal:  Mol Neurobiol       Date:  2017-01-23       Impact factor: 5.590

3.  Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control.

Authors:  H Jäkel; C Weinl; L Hengst
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

4.  BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.

Authors:  J-J Lee; J-S Lee; M N Cui; H H Yun; H Y Kim; S H Lee; J-H Lee
Journal:  Cell Death Dis       Date:  2014-11-20       Impact factor: 8.469

5.  Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple sphingolipid metabolic enzymes.

Authors:  Chisato Inoue; Sayaka Sobue; Naoki Mizutani; Yoshiyuki Kawamoto; Yuji Nishizawa; Masatoshi Ichihara; Toshiyuki Takeuchi; Fumihiko Hayakawa; Motoshi Suzuki; Tetsuro Ito; Yoshinori Nozawa; Takashi Murate
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

6.  Critical roles of Myc-ODC axis in the cellular transformation induced by myeloproliferative neoplasm-associated JAK2 V617F mutant.

Authors:  Megumi Funakoshi-Tago; Kazuya Sumi; Tadashi Kasahara; Kenji Tago
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

7.  Involvement of KRAS G12A mutation in the IL-2-independent growth of a human T-LGL leukemia cell line, PLT-2.

Authors:  Naoki Mizutani; Hiromi Ito; Kazumi Hagiwara; Misa Kobayashi; Asuka Hoshikawa; Yayoi Nishida; Akira Takagi; Tetsuhito Kojima; Motoshi Suzuki; Yosuke Osawa; Kazunori Ohnishi; Masanori Daibata; Takashi Murate
Journal:  Nagoya J Med Sci       Date:  2012-08       Impact factor: 1.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.